Dan Ollendorf is Director of Value Assessment and Global Health Initiatives at the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts University Medical Center, as well as Assistant Professor of Medicine.  An internationally recognized expert in health technology assessment (HTA), Dan’s research interests including expanding the use of HTA and economic evaluation in developing and rapidly-growing economies, as well as refinement and use of value assessment tools in the US and other developed settings.  Prior to joining CEVR, Dan was Chief Scientific Officer for the Institute for Clinical and Economic Review (ICER) for over 10 years, where he was responsible for the conduct of systematic reviews of the comparative effectiveness of high impact health care technologies, integration of decision analysis and budgetary impact modeling into reviews of clinical evidence, engagement and collaboration with multiple stakeholders, and coordination as well as scientific oversight of the broader health technology assessment process.  His 30 years of health care experience also include work in the hospital, informatics, insurance, managed care, and consulting sectors.

Dan holds a Ph.D. in clinical epidemiology from the University of Amsterdam, a Master’s of Public Health from Boston University, and a Bachelor of Arts from the University of Rochester.  He has authored over 60 peer-reviewed articles in major journals, and was on the Editorial Board of the Journal of Managed Care Pharmacy from 2009-2012.  Dan currently serves on the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC), the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) HTA Council Working Group, and the Policy Forum of Health Technology Assessment International (HTAi).